midazolam and mdl 100240

midazolam has been researched along with mdl 100240 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, JS; Cirillo, I; Howell, SR; Martin, LL; Martin, NE	1

Trials

1 trial(s) available for midazolam and mdl 100240

Article	Year
No clinically relevant CYP3A induction with the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240. Journal of clinical pharmacology, 2004, Volume: 44, Issue:4 Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzazepines; Cytochrome P-450 CYP3A; Enzyme Induction; Female; Humans; Male; Midazolam; Middle Aged; Neprilysin; Oxidoreductases, N-Demethylating; Pyridines	2004

Article

Year

No clinically relevant CYP3A induction with the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240.

Journal of clinical pharmacology, 2004, Volume: 44, Issue:4

Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzazepines; Cytochrome P-450 CYP3A; Enzyme Induction; Female; Humans; Male; Midazolam; Middle Aged; Neprilysin; Oxidoreductases, N-Demethylating; Pyridines

2004